Residual tumor cells are unique cellular targets in glioblastomaMartin Glas, Björn Scheffler, Anja Schramme et al.|Annals of Neurology|2010Cited by 132
Dose escalation with intraoperative radiotherapy in newly diagnosed glioblastoma (INTRAGO-II): an open-label, multicentre, randomised, controlled, phase 3 trialFrank A. Giordano, Piotr Pater, Oliver Ganslandt et al.|The Lancet Oncology|2026Cited by 1